← Back
$SPRY All transactions

ARS Pharmaceuticals, Inc.

A

$ Value

$0

Shares

30,000

Price

$0

Filed

Jun 27

Insider

Name

Thompson Peter A.

Title

CIK

0001357522

Roles

Director

Transaction Details

Transaction Date

2025-06-25

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

30,000

Footnotes

The shares subject to the option will vest in full on the earlier of June 25, 2026 or the date of the Issuer's 2026 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors. | Pursuant to an agreement with OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof, to OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments VI, LP.

Filing Info

Accession No.

0001415889-25-018387

Form Type

4

Issuer CIK

0001671858

Thompson Peter A.'s History

Date Ticker Type Value
2025-11-26 SION $71K
2025-11-25 SION $530K
2025-11-24 SION $4.2M
2025-06-27 CRVS X $4.9M
2025-06-27 CRVS $4.9M
2025-06-27 CRVS X $0
2025-06-25 SPRY A $0
2025-06-16 EWTX A $0
2025-06-12 CRVS A $0
2025-06-12 SION A $0

Other Insiders at SPRY (90d)

No other insider activity at this issuer in the last 90 days.